Appendix 2A - Application for quotation of securities Announcement Summary Entity name BCAL DIAGNOSTICS LIMITED Announcement Type New announcement Date of this announcement Friday November 13, 2026 The +securities to be quoted are: +Securities issued under an +employee incentive scheme that are not...
Application for quotation of securities - BDX
Filed with ASX · · 7 pages · English
Summary by 6ix AI
BCAL Diagnostics Limited has submitted an application for the quotation of securities under an employee incentive scheme. The application includes the issuance of a specific number of ordinary fully paid securities. The securities are not subject to a restriction on transfer and will rank equally with existing securities in that class. The filing confirms that the securities will not require shareholder approval under certain listing rules.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- GSS - Panel Receives Application
- Change of Director's Interest Notice
- Quarterly Activities/Appendix 4C Cash Flow Report
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
- Results of Meeting
Later from BCAL Diagnostics
- Notification of cessation of securities - BDX
- BCAL Expands Breast Cancer Biomarker Program
- Notification regarding unquoted securities - BDX
- BCAL Position on GSS-MAP Merger
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics